205 related articles for article (PubMed ID: 25705688)
21. [Comparison of two different methods for the investigation of in vitro susceptibilities of planktonic and biofilm forming Candida species to antifungal agents].
Kaynak Onurdağ F; Ozgen S; Abbasoğlu U; Gürcan IS
Mikrobiyol Bul; 2010 Oct; 44(4):619-31. PubMed ID: 21063974
[TBL] [Abstract][Full Text] [Related]
22. Growth, biofilm formation, antifungal susceptibility and oxidative stress resistance of Candida glabrata are affected by different glucose concentrations.
Ng TS; Desa MNM; Sandai D; Chong PP; Than LTL
Infect Genet Evol; 2016 Jun; 40():331-338. PubMed ID: 26358577
[TBL] [Abstract][Full Text] [Related]
23. Miconazole activity against Candida biofilms developed on acrylic discs.
Gebremedhin S; Dorocka-Bobkowska B; Prylinski M; Konopka K; Duzgunes N
J Physiol Pharmacol; 2014 Aug; 65(4):593-600. PubMed ID: 25179092
[TBL] [Abstract][Full Text] [Related]
24. In vitro antifungal effect and inhibitory activity on biofilm formation of seven commercial mouthwashes.
Fu J; Wei P; Zhao C; He C; Yan Z; Hua H
Oral Dis; 2014 Nov; 20(8):815-20. PubMed ID: 24724892
[TBL] [Abstract][Full Text] [Related]
25. Interactions between Candida albicans and Candida glabrata in biofilms: Influence of the strain type, culture medium and glucose supplementation.
Hosida TY; Cavazana TP; Henriques M; Pessan JP; Delbem ACB; Monteiro DR
Mycoses; 2018 Apr; 61(4):270-278. PubMed ID: 29274093
[TBL] [Abstract][Full Text] [Related]
26. Dissecting the anti-biofilm potency of kappa-carrageenan capped silver nanoparticles against Candida species.
Gupta P; Goel A; Singh KR; Meher MK; Gulati K; Poluri KM
Int J Biol Macromol; 2021 Mar; 172():30-40. PubMed ID: 33440209
[TBL] [Abstract][Full Text] [Related]
27. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
Cocuaud C; Rodier MH; Daniault G; Imbert C
J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622
[TBL] [Abstract][Full Text] [Related]
28. Antifungal activity of a prenylated flavonoid from Dalea elegans against Candida albicans biofilms.
Peralta MA; da Silva MA; Ortega MG; Cabrera JL; Paraje MG
Phytomedicine; 2015 Oct; 22(11):975-80. PubMed ID: 26407939
[TBL] [Abstract][Full Text] [Related]
29. Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans.
Khan MS; Ahmad I
J Ethnopharmacol; 2012 Mar; 140(2):416-23. PubMed ID: 22326355
[TBL] [Abstract][Full Text] [Related]
30. Synergistic effects of tea catechin epigallocatechin gallate and antimycotics against oral Candida species.
Ning Y; Ling J; Wu CD
Arch Oral Biol; 2015 Oct; 60(10):1565-70. PubMed ID: 26263544
[TBL] [Abstract][Full Text] [Related]
31. Effect of alkylphospholipids on Candida albicans biofilm formation and maturation.
Vila TV; Ishida K; de Souza W; Prousis K; Calogeropoulou T; Rozental S
J Antimicrob Chemother; 2013 Jan; 68(1):113-25. PubMed ID: 22995097
[TBL] [Abstract][Full Text] [Related]
32. Combination of fluconazole with silver nanoparticles produced by Fusarium oxysporum improves antifungal effect against planktonic cells and biofilm of drug-resistant Candida albicans.
Longhi C; Santos JP; Morey AT; Marcato PD; Durán N; Pinge-Filho P; Nakazato G; Yamada-Ogatta SF; Yamauchi LM
Med Mycol; 2016 May; 54(4):428-32. PubMed ID: 26092103
[TBL] [Abstract][Full Text] [Related]
33. In vitro effectiveness of anidulafungin against Candida sp. biofilms.
Rosato A; Piarulli M; Schiavone BP; Catalano A; Carocci A; Carrieri A; Carone A; Caggiano G; Franchini C; Corbo F; Montagna MT
J Antibiot (Tokyo); 2013 Dec; 66(12):701-4. PubMed ID: 24022607
[TBL] [Abstract][Full Text] [Related]
34. Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition.
Silva S; Henriques M; Martins A; Oliveira R; Williams D; Azeredo J
Med Mycol; 2009 Nov; 47(7):681-9. PubMed ID: 19888800
[TBL] [Abstract][Full Text] [Related]
35. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
[TBL] [Abstract][Full Text] [Related]
36. Interspecies variation in Candida biofilm formation studied using the Calgary biofilm device.
Parahitiyawa NB; Samaranayake YH; Samaranayake LP; Ye J; Tsang PW; Cheung BP; Yau JY; Yeung SK
APMIS; 2006 Apr; 114(4):298-306. PubMed ID: 16689830
[TBL] [Abstract][Full Text] [Related]
37. [Biofilm production and antifungal susceptibility patterns of Candida species isolated from hospitalized patients].
Demirbileki M; Timurkaynak F; Can F; Azap O; Arslan H
Mikrobiyol Bul; 2007 Apr; 41(2):261-9. PubMed ID: 17682713
[TBL] [Abstract][Full Text] [Related]
38. Ambroxol influences voriconazole resistance of Candida parapsilosis biofilm.
Pulcrano G; Panellis D; De Domenico G; Rossano F; Catania MR
FEMS Yeast Res; 2012 Jun; 12(4):430-8. PubMed ID: 22315984
[TBL] [Abstract][Full Text] [Related]
39. In vitro efficacy of liposomal amphotericin B, micafungin and fluconazole against non-albicans Candida species biofilms.
Kawai A; Yamagishi Y; Mikamo H
J Infect Chemother; 2015 Sep; 21(9):647-53. PubMed ID: 26141813
[TBL] [Abstract][Full Text] [Related]
40. Effect of silver nanoparticles on Candida albicans biofilms: an ultrastructural study.
Lara HH; Romero-Urbina DG; Pierce C; Lopez-Ribot JL; Arellano-Jiménez MJ; Jose-Yacaman M
J Nanobiotechnology; 2015 Dec; 13():91. PubMed ID: 26666378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
